Scholars Central

Short communicationPublished 2017

Evaluation on Thrombotic Events Frequency in JAK2 V617F Positive Patients

Authors: RM Freitas, FC Guia, LM Nascimento, A Atalla, A E Hallak, MO Santos, CMC Maranduba

Journal of Hematology & Thromboembolic Diseases

Volume 5 · Issue 6 · Pages 1–2

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

The Polycythemia Vera is a myeloproliferative neoplasia whose overall incidence is 0.7-2.6 cases per 100.000 inhabitants/year; 92.3% of the patients were positive to the JAK2 V617F mutation (exon 14) and 7.7% were negative also to the mutations on the exon 12. Around 29.16% of the JAK2 V617F positive patients had arterial or venous thrombosis. The percentage of patients with the JAK2 V617F mutation and the frequency of thrombosis in PV JAK2 positive patients demonstrated in our study are according to the data presented in the literature.

Subjects

Haematology

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Hematology & Thromboembolic Diseases
  • SubjectHaematology
  • BylineArticles whose byline prints “RM Freitas”
  • BylineArticles whose byline prints “FC Guia”
  • BylineArticles whose byline prints “LM Nascimento”
  • BylineArticles whose byline prints “A Atalla”
  • BylineArticles whose byline prints “A E Hallak”
  • BylineArticles whose byline prints “MO Santos”
  • BylineArticles whose byline prints “CMC Maranduba”